Sky Labs received UK regulatory approval for CART PLATFORM, a cuffless ring-based blood pressure monitor that integrates wearable hardware, mobile app, and cloud analytics. The authorization enables prescription distribution through UK pharmacies and hospitals, establishing clinical-grade continuous blood pressure monitoring as an accessible diagnostic tool.
Key Points
- MHRA approval enables prescription-based UK distribution through pharmacies and hospitals
- Cuffless ring design enables continuous monitoring without occlusion or patient burden
- Integrated platform architecture combines hardware, app, and server for real-time clinical data
Longevity Analysis
Continuous, unobtrusive blood pressure monitoring shifts from episodic clinical measurement to longitudinal signal interpretation. This removes a major barrier to early detection of hemodynamic dysfunction—the systems that govern circulation, stress response, and autonomic function are now continuously observable rather than intermittently sampled. Regulatory validation in multiple markets positions this class of device as a foundation for personalized cardiovascular risk assessment and intervention timing, particularly relevant as blood pressure dynamics predict morbidity and mortality more accurately than single readings.
Original published by LT Wire.